Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score"

Moulin, P; Dufour, R; Averna, M; Arca, M; Cefalu, AB; Noto, D; D'Erasmo, L; Di Costanzo, A; Marcais, C; Walther, LAAS; Banach, M; Boren, J; Cramb, R; Gouni-Berthold, I; Hughes, E; Johnson, C; Pinto, X; Reiner, Z; van Lennep, JR; Soran, H; Stefanutti,

Bruckert, E (reprint author), Hop La Pitie Salpetriere, Inst E3M, Endocrinol Metab & Prevent Cardiovasc, 47-83 Blvd Hop, F-75013 Paris, France.; Bruckert, E (reprint author), Hop La Pitie Salpetriere, IHU Cardiometab ICAN, 47-83 Blvd Hop, F-75013 Paris, F

ATHEROSCLEROSIS, 2018; 275 (): 265

Abstract

Familial chylomicronaemia syndrome (FCS) is a rare, inherited disorder characterised by impaired clearance of triglyceride (TG)-rich lipoproteins from......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索